254 related articles for article (PubMed ID: 32411571)
21. Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme.
Kong Y; Ruan L; Qian L; Liu X; Le Y
J Neurosci; 2010 Sep; 30(35):11848-57. PubMed ID: 20810904
[TBL] [Abstract][Full Text] [Related]
22. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's disease amyloid peptide.
Wiesehan K; Stöhr J; Nagel-Steger L; van Groen T; Riesner D; Willbold D
Protein Eng Des Sel; 2008 Apr; 21(4):241-6. PubMed ID: 18252750
[TBL] [Abstract][Full Text] [Related]
24. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin D: Analysis of its potential role as an amyloid beta degrading protease.
Gallwitz L; Schmidt L; Marques ARA; Tholey A; Cassidy L; Ulku I; Multhaup G; Di Spiezio A; Saftig P
Neurobiol Dis; 2022 Dec; 175():105919. PubMed ID: 36347423
[TBL] [Abstract][Full Text] [Related]
26. Targeted hydrolysis of Beta-amyloid with engineered antibody fragment.
Kasturirangan S; Sierks M
Curr Alzheimer Res; 2010 May; 7(3):214-22. PubMed ID: 20088808
[TBL] [Abstract][Full Text] [Related]
27. [Biological characteristics of amyloid precursor protein and Alzheimer's disease].
Fukatsu R; Tsuzuki K; Takamaru Y; Hayashi Y; Sasaki N; Yoshida T; Midorikawa Y; Fujii N; Takahata N
Rinsho Byori; 1996 Mar; 44(3):213-24. PubMed ID: 8857163
[TBL] [Abstract][Full Text] [Related]
28. A Synthetic Pro-Drug Peptide Reverses Amyloid-β-Induced Toxicity in the Rat Model of Alzheimer's Disease.
Kumar S; Srivastav S; Fatima M; Giri RS; Mandal B; Mondal AC
J Alzheimers Dis; 2019; 69(2):499-512. PubMed ID: 30958369
[TBL] [Abstract][Full Text] [Related]
29. Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes.
Deb S; Wenjun Zhang J; Gottschall PE
Brain Res; 2003 Apr; 970(1-2):205-13. PubMed ID: 12706262
[TBL] [Abstract][Full Text] [Related]
30. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
31. Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
Rofo F; Metzendorf NG; Saubi C; Suominen L; Godec A; Sehlin D; Syvänen S; Hultqvist G
Alzheimers Res Ther; 2022 Dec; 14(1):180. PubMed ID: 36471433
[TBL] [Abstract][Full Text] [Related]
32. Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro.
Liao MC; Van Nostrand WE
Biochemistry; 2010 Feb; 49(6):1127-36. PubMed ID: 20050683
[TBL] [Abstract][Full Text] [Related]
33. Clearance of amyloid-beta peptide by neuronal and non-neuronal cells: proteolytic degradation by secreted and membrane associated proteases.
Panchal M; Lazar N; Munoz N; Fahy C; Clamagirand C; Brouard JP; Dubost L; Cohen P; Brakch N; Rholam M
Curr Neurovasc Res; 2007 Nov; 4(4):240-51. PubMed ID: 18045149
[TBL] [Abstract][Full Text] [Related]
34. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
[TBL] [Abstract][Full Text] [Related]
35. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
Huang HC; Jiang ZF
J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
[TBL] [Abstract][Full Text] [Related]
36. Molecular Mechanism of Zinc-Dependent Oligomerization of Alzheimer's Amyloid-β with Taiwan (D7H) Mutation.
Kechko OI; Adzhubei AA; Tolstova AP; Indeykina MI; Popov IA; Zhokhov SS; Gnuchev NV; Mitkevich VA; Makarov AA; Kozin SA
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511001
[TBL] [Abstract][Full Text] [Related]
37. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.
Bates KA; Verdile G; Li QX; Ames D; Hudson P; Masters CL; Martins RN
Mol Psychiatry; 2009 May; 14(5):469-86. PubMed ID: 18794889
[TBL] [Abstract][Full Text] [Related]
38. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
[TBL] [Abstract][Full Text] [Related]
39. Virtual histology of Alzheimer's disease: Biometal entrapment within amyloid-β plaques allows for detection via X-ray phase-contrast imaging.
Chourrout M; Sandt C; Weitkamp T; Dučić T; Meyronet D; Baron T; Klohs J; Rama N; Boutin H; Singh S; Olivier C; Wiart M; Brun E; Bohic S; Chauveau F
Acta Biomater; 2023 Oct; 170():260-272. PubMed ID: 37574159
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
